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Abstract: Citral (CIT), which contains the chiral enantiomers, neral (cis) and 
geranial (trans), is the majority monoterpene from Lippia alba and Cymbopogon 
citratus. The present study aimed to evaluate CIT for antinociceptive and anti-
inflammatory activities in rodents. Antinociceptive and anti-inflammatory 
effects were studied by measuring nociception through acetic acid and formalin 
tests, while inflammation was verified by inducing peritonitis and paw edema 
with carrageenan. All tested doses of CIT had significant protection (p<0.001) 
against acetic acid (0.8%) induced nociceptive behavior and the effects were 
also similar to morphine while formalin induced nociception was significantly 
protected (p<0.05) only at higher dose (200 mg/kg) of CIT in the first phase 
of the test. CIT significantly reduce (p<0.001) nociceptive behavior emanating 
from inflammation in second phase at all the doses.The pretreatment with 
CIT (100 and 200 mg/kg) significantly reduced the paw edema induced by 
carrageenan. Moreover, systemic treatment with CIT (100 and 200 mg/kg) 
significantly reduced (p<0.001) the leukocyte migration in the carrageenan-
induced migration to the peritoneal cavity. Our investigation shows that CIT 
possess significant central and peripheral antinociceptive effects. It was also 
verified an anti-inflammatory activity. All together these results suggest that 
CIT might represent important tool for treatment of painful conditions.
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Introduction
 Treatments of some painful conditions, 
such as inflammatory and neurogenic pain, are often 
unsatisfactory because its etiology is heterogeneous 
and the underlying pathophysiology mechanisms are 
complex (Batista et al., 2010). Moreover, currently 
available drugs that provide relief from these painful 
conditions are effective only in a fraction of patients. In 
general, these drugs present low efficacy and numerous 
side effects (Basbaum, 1999; Mendell & Sahenk, 2003). 
In this context, natural products that present fewer side 
effects emerge as interesting therapeutic resources for 
the development of new drugs for the management of 
certain painful states (McCurdy & Scully, 2005; Batista 
et al., 2010).
 An increasing number of studies have 
demonstrated that essential oils derived plant exhibit 
a variety of biological properties, such as analgesic 
(McCurdy & Scully, 2005), hypotensive (Menezes 
et al., 2010) and anticonvulsant activities (Quintans-
Júnior et al., 2008a; Silva et al., 2010). Monoterpenes 
are the primary components of these essential oils and 
the effects of many medicinal herbs have been attributed 
to them (Lima-Accioly et al., 2006; Quintans-Júnior 
et al., 2008b), including the studies realized by our 
group (De Sousa et al., 2006; 2007; Melo et al., 2010; 
Quintans-Júnior et al., 2010; Guimarães et al., 2010).
 In this regard, preliminary pharmacological 
screening realized with the essential oil of the 
Cymbopogon winterianus (rich in citronellal, citronellol 
and citral) demonstrates CNS depressant, anticonvulsant, 
hypotensive, vasorelaxat and antinociceptive activities 
in rodents (Quintans-Júnior et al., 2008a; Menezes et 
al., 2010; Leite et al., 2010). Gurgel do Vale et al. (2002) 
demonstrates that Lippia alba essential oil (rich in citral 
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and myrcene) possess anxiolytic and depressant effects 
in experimental animals. In same study, authors showed 
that isolated compound (citral) possess CNS depressant 
activity in rodents. However, little is known about the 
possible antinociceptive and anti-inflammatory activities 
of citral (CIT).
 Thus, the purpose of the present study was to 
evaluate both antinociceptive and anti-inflammatory 
activities of CIT in rodents.
Material and Methods 
Chemicals
 Acetic acid, carrageenan, diazepam, citral 
(minimum 95%, mixture of cis (1a) and trans (1b) isomers, 
3,7-dimethyl-2,6-octadienal (1)), and polyoxyethylene-
sorbitan monolate (Tween 80) were purchased from Sigma 
(USA). Morphine (MOR) and Indomethacin (INDO), 
were purchased from União Química Farmacêutica 
Nacional (Brazil). The citral (CIT) was administered 
intraperitoneally (i.p.) in volumes of 0.1 mL/10 g and 
the doses (50, 100 or 200 mg/kg) were adjusted for those 
respective volumes.
CHO
CHO
1b1a
Animals
 Male Swiss mice (31-36 g) and male Wistar rats 
(150-170 g), 2-3 months of age, were used throughout this 
study. The animals were randomly housed in appropriate 
cages at 21±2 ºC on a 12 h light/dark cycle (lights on 6:00-
18:00 h) with free access to food and water. Experiments 
were carried out between 9:00 am and 14:00 pm in a quiet 
room. Nociceptive and inflammatory tests were carried 
out by the same visual observer and all efforts were made 
to minimize the number of animals used as well as any 
discomfort. Experimental protocols were approved by the 
Animal Care and Use Committee (CEPA/UFS # 26/09) at 
the Federal University of Sergipe and handling procedures 
were in accordance with International Association for the 
Study of Pain guidelines for the use of animals in pain 
research (Zimmermann, 1983). 
Antinociceptive activity
 Acetic acid-induced writhing
 The acetic acid test was done using the method 
described by Koster et al. (1959) and modified by 
Gaertner et al. (1999). Initially, the mice were divided 
into five groups (n=8, per group). Subsequently, CIT (50, 
100 or 200 mg/kg), vehicle (saline+Tween 80 0.2%), and 
MOR (5 mg/kg) were administered i.p. 30 min before an 
injection of 0.25 mL per animal of the acetic acid (0.8%). 
Each animal was isolated in an individual observation 
chamber and 5 min after acetic acid injection the 
cumulative number of writhing responses was recorded 
for 15 min.
 Formalin induced nociception
 The observation chamber was a glass box of 30 
cm diameter on an acrylic transparent plate floor. Beneath 
the floor, a mirror was mounted at a 45° angle to allow 
clear observation of the paws of the mice. The animals 
were treated with the vehicle (saline+Tween 80 0.2%), 
CIT (50, 100, and 200 mg/kg, i.p.), or the reference drug 
(MOR, 5 mg/kg, i.p.) 30 min before the formalin injection. 
Each mouse was placed in the chamber more than 5 min 
before treatment in order to allow acclimatization to the 
new environment. The formalin test was carried out as 
described by Hunskaar & Hole (1987). Twenty microliters 
of a 1.0% formalin solution (0.92% formaldehyde) in a 
phosphate-buffer (pH 7.2) were injected into the dorsal 
surface of the left hind paw using a microsyringe with a 
26-gauge needle. Each animal was then returned to the 
chamber and the amount of time that the animal spent 
licking the injected paw was considered to be indicative of 
pain. Two distinct phases of intensive licking activity were 
identified: an early acute phase and a late or tonic phase 
(0-5 and 15-30 min after formalin injection, respectively) 
(Le Bars et al., 2001).
Anti-inflammatory activity
 Leukocyte migration to the peritoneal cavity
 The leukocyte migration was induced by injection 
of carrageenan (1% 0.25 mL/cavity) into the peritoneal 
cavity of mice 30 min after administration of CIT (50, 100, 
and 200 mg/kg, i.p.) or dexamethasone (2 mg/kg, s.c., n=6 
per group) by modification of the technique previously 
described by Bastos et al. (2007). The mice were euthanized 
by cervical dislocation 4 h after carrageenan injection. 
Shortly after, phosphate buffered saline (PBS) containing 
EDTA (1 mM, i.p., 10 mL) was injected. Immediately a 
brief massage was done for further fluid collection, which 
was centrifuged (2000 rpm, 5 min) at room temperature. 
The supernatant was disposed and 1 mL of PBS was 
introduced to the precipitate. An aliquot of 10 μL from 
this suspension was dissolved in 200 μL of Turk solution 
and the total cells were counted in a Neubauer chamber, 
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under optic microscopy. The results were expressed as the 
number of leukocytes/mL. The percentage of the leukocyte 
inhibition =(1-T/C) x 100, where T represents the treated 
groups leukocyte counts and C represents the control group 
leukocyte counts.
Carrageenan-induced paw edema test
 Acute hind paw edema was produced by injecting 
0.1 mL of carrageenan (1%, prepared as a suspension 
in distillate water plus Tween-80 at 0.2%) locally into 
the subplantar aponeurosis of the right hind paw of rats 
(Winter et al., 1962). Animals were divided into five 
groups (n=6, per group). CIT (50, 100 or 200 mg/kg, i.p.), 
vehicle (saline+Tween 80 0.2%) or the standard drug 
indomethacin (INDO, 10 mg/kg, p.o.) was administered 
before the carrageenan-induced paw edema. CIT and INDO 
were administered 1 h prior to injection of carrageenan 
(Amresh et al., 2007). Right paw volume was measured by 
the dislocation of the water column of a plethysmograph 
(EFF-304, Insight®, Brazil) immediately after carrageenin 
application (time zero) and at 1, 2, 3, and 4 h after its 
administration.
Statistical analysis
 The data obtained were evaluated by one-way 
analysis of variance (ANOVA) followed by Tukey’s test 
for antinociceptive and anti-inflammatory activities. In all 
cases differences were considered significant if p<0.05. 
The percentile of inhibition of edema volume between 
treated and control group (vehicle) was calculated using 
the following formula: Inhibition % = 100 x (Vc - Vt)/Vc. 
Where Vc and Vt represent mean increase in paw volume 
in control and treated groups, respectively. 
Results and Discussion
 Initially, antinociceptive activity of CIT was 
evaluated by using the writhing test. Intraperitoneal (i.p.) 
administration of CIT, in all doses, 30 min. before the 
acid injection, produced a significant (p<0.001) inhibition 
of acetic acid-induced abdominal constrictions in mice 
(Figure 1). MOR (5 mg/kg), a standard drug, used as 
positive control, also produced significant inhibition of 
acetic acid-induced writhing response. 
 Acetic acid-induced abdominal constriction 
is a standard, simple, and sensitive test for measuring 
analgesia induced by both opioids and peripherally acting 
analgesics (Hunskaar & Hole, 1987). In acetic acid-induced 
abdominal writhing, pain is elicited by the injection of 
an irritant such as acetic acid into the peritoneal cavity 
which produces episodes of characteristic stretching 
(writhing) movements, and inhibition of the number of 
episodes by analgesics is easily quantifiable. Moreover, 
it is already well documented that the quantification of 
prostaglandins by radioimmunoassay in the peritoneal 
exudates of rodents obtained after the i.p. administration 
of acetic acid demonstrated high levels of prostaglandins 
PGE2 and PGF2α during 0.5 h after stimulus (Deraedt et 
al., 1980). These results support the hypothesis of CIT 
participation in the inhibition of prostaglandin synthesis; 
the nociceptive mechanism involves the process or release 
of arachidonic acid metabolites via cyclooxygenase (COX) 
and prostaglandin biosynthesis (Duarte et al., 1988) during 
abdominal writhing induced by acetic acid. Although, 
this method presents a good sensitivity, it shows poor 
specificity (Le Bars et al., 2001).
 Thus, to avoid misinterpretation of the results, 
in the present study we confirmed the antinociceptive 
effect of CIT in a model of inflammatory nociception, the 
formalin test, which has two distinctive phases that can 
possibly indicate different types of nociception (Hunskaar 
& Hole, 1987). CIT produces antinociceptive effects on 
both first (0-5 min) and second phases (15-30 min) of 
formalin induced nociception. The early phase, named 
neurogenic nociception, is a result of direct stimulation of 
nociceptors and reflects centrally mediated nociception; 
the late phase, named inflammatory nociception, is caused 
by local inflammation with a release of inflammatory and 
hyperalgesic mediators (Hunskaar & Hole, 1987). First 
phase was blocked only at 200 mg/kg (p<0.001) whereas 
the higher doses of CIT (100 and 200 mg/kg) significantly 
(p<0.001) blocked the inflammatory nociception. CIT was 
found to inhibit the inflammation induced nociception 
better than the neurogenic nociception. MOR (5 mg/kg) 
was significantly active (p<0.001) in the both phases of in 
formalin test (Figure 2). 
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Figure 1. Effects of CIT or MOR on the acetic acid-induced 
writhing test in the absence and presence of naloxone in mice. 
Vehicle (control), CIT (50, 100 or 200 mg/kg) or morphine 
(MOR) were administered i.p. 0.5 h before acetic acid injection. 
Each column represents mean±SEM. n=8; *p<0.001 vs control 
(ANOVA followed by Tukey’s test).
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Figure 2. Effects of CIT on the formalin-induced nociception 
in mice. Vehicle (control), CIT (50, 100 and 200 mg/kg) or 
morphine (MOR) were administered i.p. 0.5 h before formalin 
injection. A. Represents the first phase and B. represents second 
phase of formalin-induced nociception. Each column represents 
mean±SEM. n=8; *p<0.05 or **p<0.001 vs control (ANOVA 
followed by Tukey’s test).
 In this regards, Waning et al. (2007) 
demonstrated that the capsaicin-sensitive transient 
receptor potential vaniloid 1 (TRPV1), which plays an 
important role in pain transduction, is one of the Ca+2 
influx channels involved in cell migration. It was also 
shown that TRPV1 activation increases the expression 
of the TNF receptor 1 (TNFR1) by a ROS-dependent 
mechanism (Ma et al., 2009). According to Stotz et al. 
(2008) partial TRPV1 agonists, such as CIT, might be 
useful in anti-inflammatory and analgesic compounds. 
 Since in previous nociception tests, CIT showed 
better action in inflammatory pain, we verified the 
effects of CIT in tests of acute inflammation. Initially, 
we performed the carrageenan-induced leukocytes 
migration to the peritoneal cavity. Figure 3 shows the 
inhibitory effect of CIT (higher doses) on leukocytes 
migration after 4 h of the stimulus (p<0.001). Standard 
drug, dexamethasone (Dexa, 2 mg/kg, s.c.) significantly 
inhibited (p<0.001) the carrageenan-induced leukocytes 
migration to the peritoneal cavity. 
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Figure 3. Effect of CIT on leukocyte migration into the 
peritoneal cavity induced by carrageenan in mice. Groups of 
mice were pre-treated with vehicle (control), CIT (50, 100 or 
200 mg/kg, i.p.) or dexamethasone (Dexa, 2 mg/kg, s.c.) 0.5 h 
before carrageenan (1% 0.25mL/cavity i.p.) induced peritonitis. 
Cell counts were performed at the time 4 h after the injection of 
carrageenan. Each value represents the mean±SEM. Asterisks 
denote statistical significance, *p<0.001 related to control 
group. ANOVA followed by Tukey’s test (n=6, per group).
 Cell recruitment during inflammation depends 
on the orchestrated release of local mediators that 
are responsible for local vascular and tissue changes 
as well as for the recruitment of host defense cells 
(Luster et al., 2005). The inflammation induced by 
carrageenan involves cell migration, plasma exsudation 
and production of mediators, such as nitric oxide, 
prostaglandin E2, interleukin (IL)-1β, IL-6 and tumor 
necrosis factor (TNF)-α (Salvemini et al., 1996; Loram et 
al., 2007). Those mediators are able to recruit leukocytes, 
such as neutrophils, in several experimental models. CIT 
inhibited leukocyte migration induced by i.p. injection 
of carrageenan (in peritonitis model) in higher doses. A 
putative mechanism associated with this activity may 
be inhibition of the synthesis of many inflammatory 
mediators whose involvement in the cell migration 
is well established. In this regards, Katsukawa et al. 
(2010) identified CIT as a suppressor of COX-2 and an 
activator of peroxisome proliferator-activated receptors 
(PPAR) α and γ. Moreover, Lee et al. (2008) showed 
that CIT inhibits NO generation through suppression 
of iNOS expression via inhibition of NF-κB activation. 
 Besides, an additionally test was performed to 
verify the effects of CIT in the inflammation, by using 
carrageenan-induced paw edema test. The initial phase 
of carrageenan paw edema is mediated by histamine and 
serotonin, while the mediators in the later phase were 
suggested to be arachidonate metabolites (prostaglandins 
and leukotrienes) producing an edema dependent on 
the mobilization of neutrophils (Vinegar et al., 1987; 
Hwang et al.; 1996). Moreover, it should be taken into 
consideration that the mechanism involved in the genesis 
of the carrageenan-induced edema can cause the release of 
prostaglandins and kinins, among other substances (Garcia-
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Leme et al., 1973). In our experiments the edematous 
response was significantly suppressed in rats pre-treated 
with the CIT in the first phase of the edema, suggesting an 
inhibitory effect on the release of histamine and/or serotonin. 
In addition, CIT showed a significant inhibition of the 
edema in the second and third phase of edema, suggesting 
an inhibition of 5-lipoxygenase and/or cyclooxygenase, 
both enzymes involved in the formation of prostaglandins 
and leukotrienes. This edematous response was also 
significantly reduced in rats pre-treated with indomethacin, 
a compound known to be a cyclooxygenase inhibitor. 
 It can be concluded that CIT is endowed with 
peripheral antinociceptive property as well as anti-
inflammatory activity. The precise mechanisms through 
which CIT exerts its action are currently under investigation, 
but possibly it could be related to the arachidonic 
acid cascade and/or modulation of pro-inflammatory 
molecules production. Therefore, this compound will be of 
potential benefit in the management of inflammatory pain 
conditions.
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